Apr 20,2014

Welby Inc. announced that it has received funding from Dentsu Innovation Partners Inc.

Welby Inc. announced that it has received a round of funding from new investor Dentsu Digital Investment Business Limited Partnership, a fund managed by Dentsu Innovation Partners Inc. on April 21, 2014. The company issued shares by third-party allocation to the investor.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 18,2020

Voluntis obtains €3 million of additional non-dilutive loans and optimizes its existing financing

Voluntis, a leader in the field of digital therapeutics, announces that it has been granted new state-guaranteed loans (Prêt Garanti par l’Etat, or PGE in France) for a total amount of €3 million from BNP Paribas and Crédit du Nord and the optimization of the Company’s financial structure.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Sep 09,2014

Glen Tullman Launches Livongo Health to Empower Consumers with Chronic Conditions to Live Better, Beginning with Diabetes

 Livongo Health™, a consumer digital health company, launched today with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information, and support from their chosen care team. The company secured initial funding from 7wire Ventures (run by Tullman and long-time partner Lee Shapiro) and a recent $10 million Series A funding round from General Catalyst Partners. Hemant Taneja, Managing Director at General Catalyst said, "We're excited to partner with Glen and team to help accomplish their mission. We think that companies like Livongo can reduce healthcare costs by $100 billion in diabetes alone."

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 29,2014

Boston Business Journal: GNS Healthcare raises $10M for big data

GNS Healthcare Inc. has raised a $10 million Series B funding round led by existing investor Cambia Health Solutions, based in Portland Oregon. New investors, California�s Heritage Provider Network and Mitsui & Co also joined the round. The announcement follows the Cambridge company�s expansion to a second office in Austin, Texas, and a plan to grow head count to 80 from 50 by year�s end, CEO Colin Hill said. Cambridge-based GNS Healthcare provides data analytics to biotechnology companies including Biogen Idec and Genzyme Corp., health insurers like Aetna and research hospital powerhouses like Dana-Farber Cancer Institute and Brigham and Women�s Hospital. Proceeds of the financing will be used to expand GNS Healthcare�s business across the health care industry.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 16,2014

InSilico Medicine Receives Seed Funding from Deep Knowledge Ventures

InSilico Medicine, Inc. a Baltimore, Maryland-based developer of a drug knowledge management system of annotated drugs, small molecules, biologics available, received a seed funding from Deep Knowledge Ventures. Led by CEO Professor Alex Zhavoronkov, PhD, InSilico Medicine has been developing a comprehensive scalable drug knowledge management system of annotated drugs, small molecules, biologics available. The company aims to partner with top pharmaceutical companies to help analyze their drug databases and lead compounds, improve enrollment into clinical trials, and to enable them to accurately predict the efficacy of their drugs on patient groups and individual patients.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 21,2014

Welby Inc. announced that it has received funding from Dentsu Innovation Partners Inc.

Welby Inc. announced that it has received a round of funding from new investor Dentsu Digital Investment Business Limited Partnership, a fund managed by Dentsu Innovation Partners Inc. on April 21, 2014. The company issued shares by third-party allocation to the investor.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 28,2014

Voluntis Closes €20.75M Series D Financing

Voluntis, a Paris, France-based therapeutic companion software, closed a �20.75m ($29m) Series D financing. The round was co-led by Bpifrance and Innovation Capital, with participation from Vesalius Biocapital, Qualcomm, through its venture capital arm, Qualcomm Ventures, and existing investors CapDecisif Management, CM-CIC Capital Innovation and Sham. The company intends to use the funds to accelerate the development of its diabetes management solution, advance new programs in other chronic diseases and ramp up its US operations.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
May 07,2014

Flatiron Health Raises $130 Million Series B Round Led by Google Ventures and Agrees to Acquire Leading Cloud-Based EMR Company Altos Solutions

Flatiron Health, developers of the OncoCloud� platform, today announced a $130 million raise for its Series B venture capital round. The financing round is being led by Google Ventures, with participation from existing investors First Round Capital and Laboratory Corporation of America Holdings (LabCorp�). As a part of the financing, Andrew Conrad, Director at Google[X], will join Flatiron Health�s board of directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 10,2014

Syapse Raises $10 Million Series B Financing Led by Safeguard Scientifics

Syapse, creators of the Precision Medicine Data Platform, today announced that it raised $10 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor, The Social+Capital Partnership. This financing will enable Syapse to extend its lead in helping healthcare providers deploy precision medicine programs to utilize genomics and clinical data to support treatment decisions. In addition, Syapse will use proceeds to expand sales, marketing and client services, as well as further accelerate product development. To date, Syapse has raised a total of $14.5 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 23,2014

COTA Closes $3.7M, Plans To Gain Another $3.3 In Series A Funding For Cancer Data In The Cloud

Cancer data platform COTA (Cancer Outcomes Tracking and Analysis) has announced the close of $3.7 million in a planned $7 million Series A funding round led by Horizon Healthcare Services, with participation from Med-Metrix. COTA is a cloud-based program which collects certain cancer patient data and provides real-time genetic sorting of certain cancers. It also provides outcome tracking and reporting to cancer doctors. This could be useful in cutting down costs in cancer care and treatment and is part of a larger move in the health industry to use cloud-based data to better treat and allocate resources.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING